| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Melinda Litherland Pei | Director | 2026-05-29 | 12,787 | $1.96 | $25.00kBuy |
| Sean M. Wirtjes | CHIEF FINANCIAL OFFICER | 2026-05-29 | 12,787 | $1.96 | $25.00kBuy |
| Inese Lowenstein | Director | 2026-05-29 | 12,787 | $1.96 | $25.00kBuy |
| Kirk Malloy | Director | 2026-05-29 | 12,787 | $1.96 | $25.00kBuy |
| Robert G. Spignesi Jr. | PRESIDENT AND CEO | 2026-05-29 | 12,787 | $1.96 | $25.00kBuy |
| Sean M. Wirtjes | CHIEF FINANCIAL OFFICER | 2026-03-11 | 7,480 | $4.32 | $32.30kSell |
| John J. Addington Wilson | CHIEF OPERATING OFFICER | 2026-03-11 | 9,603 | $4.32 | $41.47kSell |
| Robert G. Spignesi Jr. | PRESIDENT AND CEO | 2026-03-10 | 17,922 | $4.11 | $73.70kSell |
| Natale S. Ricciardi | Director | 2026-02-27 | 842 | $0.75 | $631.50Buy |
| Sean M. Wirtjes | CHIEF FINANCIAL OFFICER | 2026-02-20 | 17,254 | $3.92 | $67.69kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jeffrey Lawrence Schwartz | 18.30% | 8,448,860 | $14.36M | Insider |
| Bain Capital Life Sciences Investors LLC | 18.27% | 8,434,560 | $14.34M | Institution |
| Bain Capital Life Sciences Investors LLC | 18.27% | 8,434,560 | $14.34M | Insider |
| Longitude Capital Partners II LLC | 8.87% | 4,093,159 | $6.96M | Insider |
| David Hirsch | 7.41% | 3,422,252 | $5.82M | Insider |
| Kennedy Lewis Management LP | 6.29% | 2,904,490 | $4.94M | Insider |
| Abgwtt Global Life Science Capital Partners GP Ltd | 4.00% | 1,848,296 | $3.14M | Institution |
| Richard S. Kollender | 3.49% | 1,611,327 | $2.74M | Insider |
| Robert G. Spignesi Jr. | 2.58% | 1,190,571 | $2.02M | Insider |
| Vanguard Capital Management LLC | 2.13% | 982,494 | $1.67M | Institution |